Risk of oral antifungal agent-induced liver injury in Taiwanese

British Journal of Clinical Pharmacology

Volumn 77, Issue 1, 2014, Pages 180-189

  Kao, Wei Yu ^a,d,e   Su, Chien Wei ^a,d   Huang, Yi Shin ^a,d   Chou, Yueh Ching ^a   Chen, Yi Chih ^a   Chung, Wen Hung ^b,c   Hou, Ming Chih ^a,d   Lin, Han Chieh ^a,d   Lee, Fa Yauh ^a,d   Wu, Jaw Ching ^a,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

drug induced liver injury; hepatitis; oral antifungal agents; Taiwanese

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTILIPEMIC AGENT; CHINESE DRUG; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; TERBINAFINE; TUBERCULOSTATIC AGENT; ANTIFUNGAL AGENT;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG FATALITY; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; MALE; ONYCHOMYCOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; TAIWAN; TOXIC HEPATITIS; TREATMENT DURATION; ASIAN CONTINENTAL ANCESTRY GROUP; DRUG-INDUCED LIVER INJURY; FACTUAL DATABASE; INFORMATION PROCESSING; MIDDLE AGED; MORTALITY; ORAL DRUG ADMINISTRATION; RISK FACTOR; TIME; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; DATABASES, FACTUAL; DATASETS AS TOPIC; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; TAIWAN; TIME FACTORS; YOUNG ADULT;

EID: 84891064488     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12178     Document Type: Article

References (41)

1. Lee WM,. Drug-induced hepatotoxicity. N Engl J Med 2003; 349: 474-485.
2. Bjornsson E,. Review article: drug-induced liver injury in clinical practice. Aliment Pharmacol Ther 2010; 32: 3-13.
3. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM,. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-954.
4. Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J,. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-1934.
5. Chang CY, Schiano TD,. Review article: drug hepatotoxicity. Aliment Pharmacol Ther 2007; 25: 1135-1151.
6. Temple RJ, Himmel MH,. Safety of newly approved drugs: implications for prescribing. JAMA 2002; 287: 2273-2275.
7. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, Lenoir C, Lemoine A, Hillon P,. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36: 451-455.
8. Elewski B, Tavakkol A,. Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality. Ther Clin Risk Manag 2005; 1: 299-306.
9. Song JC, Deresinski S,. Hepatotoxicity of antifungal agents. Curr Opin Investig Drugs 2005; 6: 170-177.
10. Garcia Rodriguez LA, Duque A, Castellsague J, Perez-Gutthann S, Stricker BH,. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol 1999; 48: 847-852.
11. Chang CH, Young-Xu Y, Kurth T, Orav JE, Chan AK,. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis. Am J Med 2007; 120: 791-798.
12. Perveze Z, Johnson MW, Rubin RA, Sellers M, Zayas C, Jones JL, Cross R, Thomas K, Butler B, Shrestha R,. Terbinafine-induced hepatic failure requiring liver transplantation. Liver Transpl 2007; 13: 162-164.
13. Srebrnik A, Levtov S, Ben-Ami R, Brenner S,. Liver failure and transplantation after itraconazole treatment for toenail onychomycosis. J Eur Acad Dermatol Venereol 2005; 19: 205-207.
14. Agarwal K, Manas DM, Hudson M,. Terbinafine and fulminant hepatic failure. N Engl J Med 1999; 340: 1292-1293.
15. Chen QF,. Drug allergy: things you have to know about drug-induced liver injury (in Chinese). Taiwan medical news research award 2007. Available at http://www.chi-tw.org/File/AWARD/2007awardfinal.pdf (last accessed 7 June 2011).
16. Wen CP, Tsai SP, Chung WS,. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med 2008; 148: 258-267.
17. National Health Insurance Research Database. July 28, 2010. Available at http://w3.nhri.org.tw/nhird/en/Data-Subsets.html#S3 (last accessed 27 June 2013).
18. Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY,. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc 2005; 104: 157-163.
19. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML,. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011; 20: 236-242.
20. Kao WY, Hwang CY, Chang YT, Su CW, Hou MC, Lin HC, Lee FY, Lee SD, Wu JC,. Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study. Aliment Pharmacol Ther 2012; 36: 467-476.
21. Luo JC, Leu HB, Huang KW, Huang CC, Hou MC, Lin HC, Lee FY, Lee SD,. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ 2011; 183: E1345-1351.
22. Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY,. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 2011; 364: 1126-1133.
23. Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT,. Effective reduction of gastric cancer risk with regular use of non-steroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J Clin Oncol 2010; 28: 2952-2957.
24. Lee CH, Wang JD, Chen PC,. Case-crossover study of hospitalization for acute hepatitis in Chinese herb users. J Gastroenterol Hepatol 2008; 23: 1549-1555.
25. Lee CH, Wang JD, Chen PC,. Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs. Pharmacoepidemiol Drug Saf 2010; 19: 708-714.
26. Lee CH, Wang JD, Chen PC,. Risk of liver injury associated with Chinese herbal products containing Radix bupleuri in 639 779 patients with hepatitis B virus infection. PLoS One 2011; 6: e16064.
27. Anatomical Therapeutic Chemical (ATC) classification system. 2011. Available at http://www.whocc.no/atc/structure-and-principles/ (last accessed 7 June 2011).
28. Benichou C,. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol 1990; 11: 272-276.
29. Defined daily dose: definition and general considerations. 2011. Available at http://www.whocc.no/ddd/definition-and-general-considera/ (last accessed 7 June 2011).
30. Au JS, Navarro VJ, Rossi S,. Review article: drug-induced liver injury-its pathophysiology and evolving diagnostic tools. Aliment Pharmacol Ther 2011; 34: 11-20.
31. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P,. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004; 10: 1018-1023.
32. Reuben A, Koch DG, Lee WM,. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010; 52: 2065-2076.
33. Bell LN, Chalasani N,. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis 2009; 29: 337-347.
34. Danan G, Benichou C,. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-1330.
35. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF,. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297-301.
36. Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, Garcia-Munoz B, Gonzalez-Grande R, Pizarro A, Duran JA, Jimenez M, Rodrigo L, Romero-Gomez M, Navarro JM, Planas R, Costa J, Borras A, Soler A, Salmeron J, Martin-Vivaldi R, Liv SGSD-I,. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish Registry over a 10-year period. Gastroenterology 2005; 129: 512-521.
37. Bjornsson E, Olsson R,. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005; 42: 481-489.
38. Lucena MI, Andrade RJ, Kaplowitz N, Garcia-Cortes M, Fernandez MC, Romero-Gomez M, Bruguera M, Hallal H, Robles-Diaz M, Rodriguez-Gonzalez JF, Navarro JM, Salmeron J, Martinez-Odriozola P, Perez-Alvarez R, Borraz Y, Hidalgo R,. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology 2009; 49: 2001-2009.
39. Lu SN, Su WW, Yang SS, Chang TT, Cheng KS, Wu JC, Lin HH, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, Chen DS, Chen CH,. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 2006; 119: 1946-1952.
40. Chien RN, Yang LJ, Lin PY, Liaw YF,. Hepatic injury during ketoconazole therapy in patients with onychomycosis: a controlled cohort study. Hepatology 1997; 25: 103-107.
41. Bradburn MJ, Clark TG, Love SB, Altman DG,. Survival analysis Part III: multivariate data analysis-choosing a model and assessing its adequacy and fit. Br J Cancer 2003; 89: 605-611.